Many probiotics firms start with a flagship strain, then study it to determine potential health benefits. Verb Biotics flips that on its head ...

Recent research has shown that artificial bacteria, also called "synthetic probiotics", could offer a promising new approach to treating gut-brain axis disorders.

The rapid advancement of these potential biotherapeutics, called Synthetic Biotics, has been enabled by Synlogic's reproducible, target-specific drug design.

Bioma’s transparency-driven formula highlights XOS prebiotics, targeted Bifidobacterium strains, and tributyrin postbiotics—meeting rising consumer demand for non-synthetic gut health support ...

These engineered organisms, called Synthetic Biotics, are being investigated as treatments for metabolic and immunologic diseases like phenylketonuria (PKU), homocystinuria (HCU), enteric ...

BOSTON, April 18, 2023 (GLOBE NEWSWIRE) -- Verb Biotics, a microbiome innovation company, today announced that it will be participating as a next-generation biotech innovator at Ferment, Ginkgo ...

The new candidate, SYNB2081, is a synthetic biotic and is the second product to advance to clinical development through a research collaboration between Synlogic and Ginkgo Bioworks.

CAMBRIDGE, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, announced today ...

SYNB2081 is the second clinical drug candidate developed through the partnership between Ginkgo and Synlogic CAMBRIDGE, Mass. and BOSTON, Aug. 11, 2022 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX ...

SYNB2081 is the second clinical drug candidate developed through the partnership between Ginkgo and Synlogic CAMBRIDGE, Mass. and BOSTON, Aug. 11, 2022 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX ...